Cite
HARVARD Citation
Nash, P. et al. (n.d.). THU0322 Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year results from the phase 3 future 2 study. Annals of the rheumatic diseases. p. 379. [Online].